| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.510270128 |
| P698 | PubMed publication ID | 9425935 |
| P50 | author | Anna L. Fracanzani | Q42229794 |
| Alberto Piperno | Q56263823 | ||
| Maria Domenica Cappellini | Q56678936 | ||
| P2093 | author name string | A Vergani | |
| G Fiorelli | |||
| M Mattioli | |||
| S Fargion | |||
| M Sampietro | |||
| C Arosio | |||
| I Malosio | |||
| L Lupica | |||
| N Corbetta | |||
| P2860 | cites work | A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 |
| Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda | Q28270994 | ||
| Uroporphyrinogen decarboxylase | Q40433950 | ||
| Familial and sporadic porphyria cutanea: two different diseases | Q41953376 | ||
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association | Q42982870 | ||
| Single-tube reverse transcription and heminested polymerase chain reaction of hepatitis C virus RNA to detect viremia in serologically negative hemodialysis patients | Q43037077 | ||
| Porphyria cutanea tarda and antibodies to hepatitis C virus. | Q43038650 | ||
| HCV infection in porphyria cutanea tarda | Q43038848 | ||
| Haemochromatosis and HLA-H. | Q43725988 | ||
| Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
| Mutation analysis in hereditary hemochromatosis | Q48067239 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| The frequency of the haemochromatosis-associated genotype D6S265-1:D6S105-8 in blood donors | Q58227800 | ||
| Genetic hemochromatosis in Italian patients with prophyria cutanea tarda: possible explanation for iron overload | Q62607299 | ||
| Increased frequency of HLA-A3 in subjects with sporadic porphyria cutanea tarda | Q68096126 | ||
| Porphyria cutanea tarda and HLA-linked hemochromatosis--all in the family? | Q68989626 | ||
| The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores | Q70604551 | ||
| HLA-A3 and -B7 in porphyria cutanea tarda | Q70632666 | ||
| Allelic association of microsatellites of 6p in Italian hemochromatosis patients | Q71599206 | ||
| Iron storage in porphyria cutanea tarda | Q71665335 | ||
| Haemochromatosis and HLA-H | Q71735468 | ||
| Hepatic pathology in porphyria cutanea tarda | Q72699003 | ||
| Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations | Q73048042 | ||
| Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda | Q73048056 | ||
| Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients | Q73084533 | ||
| Measurement of liver-iron concentration in needle-biopsy specimens | Q93695357 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | porphyria cutanea tarda | Q1479497 |
| P304 | page(s) | 181-184 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda | |
| P478 | volume | 27 |
| Q62597157 | Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda |
| Q57659873 | Association between iron overload and osteoporosis in patients with hereditary hemochromatosis |
| Q62607272 | Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda |
| Q43929897 | C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria |
| Q57659875 | Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations? |
| Q74529909 | Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron |
| Q74081557 | Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients |
| Q33540057 | Cloning of the hereditary hemochromatosis gene: implications for pathogenesis, diagnosis, and screening |
| Q73489115 | Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings |
| Q24539508 | Familial Porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen Decarboxylase Mutations and Frequency of Common Hemochromatosis Alleles |
| Q35212591 | From genotype to phenotype: genetics and medical practice in the new millennium |
| Q34989227 | HFE and non-HFE hemochromatosis |
| Q36177897 | HFE gene in primary and secondary hepatic iron overload. |
| Q78553635 | HFE gene mutations and iron metabolism in Wilson's disease |
| Q30380172 | HFE gene: Structure, function, mutations, and associated iron abnormalities. |
| Q73078354 | HFE genotypes and haemochromatosis: quantifying the risks of disease |
| Q35376979 | Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy |
| Q33870226 | Haemochromatosis in the new millennium. |
| Q37213062 | Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study. |
| Q35121442 | Hemochromatosis gene modifies course of hepatitis C viral infection. |
| Q43184153 | Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors |
| Q50867909 | Hemochromatosis: genetics helps to define a multifactorial disease |
| Q50864497 | Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. |
| Q34057526 | Hepatology in the new millennium. Advances in viral hepatitis, hepatic disorders, and liver transplantation |
| Q34942588 | Human hereditary hepatic porphyrias |
| Q73876513 | Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver |
| Q53928507 | Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis |
| Q42983598 | Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C. |
| Q54074092 | Insulin resistance-associated hepatic iron overload |
| Q78554382 | Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C |
| Q35212534 | Iron as a co-morbid factor in nonhemochromatotic liver disease |
| Q43037875 | Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study |
| Q62607278 | Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease |
| Q77738423 | Molecular medicine and hemochromatosis: at the crossroads |
| Q74027228 | Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload |
| Q43790801 | Non-Transferrin-Bound Iron in Alcohol Abusers |
| Q72995518 | Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis |
| Q36267789 | Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias |
| Q43001698 | Porphyria cutanea tarda in the HFE-gene and hepatitis C virus era. |
| Q42988426 | Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† |
| Q91227989 | Porphyria cutanea tarda: Recent update |
| Q45713240 | Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency |
| Q37141723 | Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients |
| Q45721816 | Prevalence of hepatitis C virus infection in porphyria cutanea tarda |
| Q77348087 | Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease |
| Q41758986 | Revisiting various iron overload syndromes after the haemochromatosis gene discovery |
| Q34027590 | Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis |
| Q57659912 | TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda. |
| Q43929739 | The HFE gene S65C polymorphism is rare among Bulgarian porphyria cutanea tarda patients |
| Q37344035 | The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic |
| Q53242907 | The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease |
| Q73000944 | The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is His63Asp |
| Q77738395 | The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C |
| Q74694133 | Update on enzyme and molecular defects in porphyria |
| Q35363883 | Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? |
| Q83887878 | [Porphyria cutanea tarda and hemochromatosis in Spain] |
Search more.